Pilot study on B2A shows comparable results to ICBG in lumbar spine fusion
Twelve-month results of a multicenter, blinded, pilot study of a novel peptide (B2A) in promoting lumbar spine fusionJ Neurosurg Spine. 2015 Apr;22(4):358-66.
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
24 patients were included in this blinded, pilot, randomized clinical trial to evaluate a novel synthetic peptide, B2A, combined with ceramic granules and local bone autograft. Patients were randomized into one of three groups; either B2A at differing concentrations (750 or 150) combined with ceramic granules and local bone autograft at, or to iliac crest bone grafting. The results of this trial o...
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.LEARN MORE